ERBA Diagnostics, Inc., formerly IVAX Diagnostics, Inc., through its subsidiaries, develops, manufactures and markets diagnostic test kits, or assays, and automated systems that are used to aid in the detection of disease markers in the areas of autoimmune and infectious diseases. These tests, which are designed to aid in the identification of the causes of illness and disease, assist physicians in selecting appropriate patient treatment. The Company is a parent company for Delta Biologicals, S.r.l. (Delta), Diamedix Corporation (Diamedix) and ImmunoVision, Inc. (ImmunoVision). Diamedix�s products are sold in the United States and in international markets through third party distributors. Diamedix markets approximately 100 assays that the food and drug administration (FDA) has cleared. ImmunoVision is engaged in developing, manufacturing and marketing autoimmune reagents and research products for use by research laboratories and commercial diagnostic manufacturers.